kentucky glp-1 nausea class action vomiting law office The Law Offices of Timothy L. Miles kentucky glp-1 diarrhea class action

22: 719, doi: Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL

One of the most common hidden causes of weight gain is insulin resistance

Veauthier C, Gaede G, Radbruch H, Gottschalk S, Wernecke KD, Paul F

HFpEF is notoriously difficult to treat, and currently, only two drugs, the SGLT2 inhibitors dapagliflozin and empagliflozin, are FDA-approved to treat it

It alleges MEDVi was one of at least a dozen nearly identical telehealth storefronts, each with a designated OpenLoop patient waiting room, all marketing the same product through the same backend infrastructure

There is no clinical evidence that this patch provides the same therapeutic benefits as injectable GLP-1 agonists like Ozempic or Wegovy